Verification register Bio, Health & Neuro
Living definition
What is Gedatolisib (Revtorpyk)?
Drug Discovery & Development Bio, Health & Neuro
- As of
- 2026-08-20
- Revision
- 2026-08-17.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Gedatolisib (Revtorpyk) is a small-molecule inhibitor targeting the PI3K and mTOR signalling pathway, developed as a treatment for advanced breast cancer.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-08-20, verified readiness is 61 (claimed 90, reported 76, gap 29) — Critical evidence strength; current signals suggest Adopt with guardrails.
The readiness fact belongs to the canonical Readiness Verdict for Gedatolisib (Revtorpyk).
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-08-17.1
- Hash
- sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
- Approved
- 2026-08-17